Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

ArcticZymes Technologies

Mindre end 1K følgere

AZT

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Investorkonsensus

ArcticZymes Technologies is active in biotechnology. The company specializes in research and development of drugs for the treatment of autoimmune diseases. The main focus is on the development of glucans, the production of immunostimulants, and the analysis of enzymes. The vision is to test and develop the medicine and then further use it for RNA and DNA processes. The company was previously known as Biotec Pharmacon and is headquartered in Tromsø.

Læs mere
Markedsværdi
-
Aktieomsætning
-
Omsætning
104,35 mio.
EBIT %
-1,27 %
P/E
-
Udbytteafkast, %
-
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelsei går

ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and Strengthened Profitability

ArcticZymes Technologies
Selskabsmeddelelse30.10.2025, 12.46

ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 results

ArcticZymes Technologies
Pressemeddelelse30.10.2025, 12.46

ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 results

ArcticZymes Technologies

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse16.9.2025, 08.00

AZT: ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Conference

ArcticZymes Technologies
Selskabsmeddelelse14.8.2025, 16.00

ArcticZymes Technologies ASA - Mandatory notification of trades by close associates of primary insiders

ArcticZymes Technologies
Selskabsmeddelelse14.8.2025, 16.00

ArcticZymes Technologies ASA - Mandatory notification of trades by close associates of primary insiders

ArcticZymes Technologies
Selskabsmeddelelse14.8.2025, 05.00

ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growth Accelerates as Customer centric Strategy Gains Momentum

ArcticZymes Technologies
Selskabsmeddelelse14.8.2025, 05.00

ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growth Accelerates as Customer centric Strategy Gains Momentum

ArcticZymes Technologies
Selskabsmeddelelse7.8.2025, 06.31

ArcticZymes Technologies ASA: Invitation to presentation of Q2 and 6M 2025 results

ArcticZymes Technologies
Selskabsmeddelelse7.8.2025, 06.30

ArcticZymes Technologies ASA: Invitation to presentation of Q2 and 6M 2025 results

ArcticZymes Technologies
Selskabsmeddelelse16.6.2025, 05.00

AZT: ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral Vector Manufacturing.

ArcticZymes Technologies
Selskabsmeddelelse4.6.2025, 09.10

AZT: ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 2025

ArcticZymes Technologies
Pressemeddelelse4.6.2025, 09.10

ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 2025

ArcticZymes Technologies
Selskabsmeddelelse4.6.2025, 05.00

ArcticZymes Technologies AS - Mandatory notification of trade

ArcticZymes Technologies
Selskabsmeddelelse4.6.2025, 05.00

ArcticZymes Technologies AS - Mandatory notification of trade

ArcticZymes Technologies
Selskabsmeddelelse28.5.2025, 11.32

AZT: ArcticZymes and Austrian Centre of Industrial Biotechnology Extend Collaborative Research on use of Salt-Active Nucleases for Bionanoparticle Purification

ArcticZymes Technologies
Pressemeddelelse28.5.2025, 11.32

ArcticZymes Technologies: ArcticZymes and Austrian Centre of Industrial Biotechnology Extend Collaborative Research on use of Salt-Active Nucleases for Bionanoparticle Purification

ArcticZymes Technologies
Selskabsmeddelelse27.5.2025, 12.48

ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2025

ArcticZymes Technologies
Selskabsmeddelelse27.5.2025, 12.48

ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2025

ArcticZymes Technologies
Selskabsmeddelelse14.5.2025, 15.03

ArcticZymes Technologies AS - Mandatory notification of trade

ArcticZymes Technologies
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.